Vis enkel innførsel

dc.contributor.authorBiedenbach, Thomas
dc.contributor.authorMüller, Ralf
dc.date.accessioned2016-07-28T14:15:13Z
dc.date.accessioned2016-08-23T11:56:00Z
dc.date.available2016-07-28T14:15:13Z
dc.date.available2016-08-23T11:56:00Z
dc.date.issued2012
dc.identifier.citationInternational Journal of Project Management 2012, 30(5):621-635nb_NO
dc.identifier.issn0263-7863
dc.identifier.urihttp://hdl.handle.net/11250/2401079
dc.descriptionThis is the accepted, refereed and final manuscript to the articlenb_NO
dc.description.abstractThis study explores how absorptive, innovative and adaptive capabilities within early project phases affect project and portfolio performance in pharmaceutical and biotechnology R&D organizations. A sequential qualitative – quantitative mixed method was used with 18 interviews and 80 responses to an online survey. The results show effects of absorptive, innovative and adaptive capabilities on short- and long-term project performance and portfolio performance. Absorptive and adaptive capabilities are the primary contributors to the performance outcome, whereas innovative capabilities are a minor contributor. Managerial and theoretical implications are discussed.nb_NO
dc.language.isoengnb_NO
dc.publisherElseviernb_NO
dc.titleAbsorptive, innovative and adaptive capabilities and their impact on project and project portfolio performancenb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.date.updated2016-07-28T14:15:13Z
dc.source.journalInternational Journal of Project Managementnb_NO
dc.identifier.doi10.1016/j.ijproman.2012.01.016
dc.identifier.cristin924013
dc.description.localcode1, Forfatterversjonnb_NO


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel